Biomarin Pharmaceutical (BMRN) Debt to Equity (2010 - 2024)
Biomarin Pharmaceutical (BMRN) recorded quarterly Debt to Equity of $0.09 in Q2 2024, down 3.93% on a QoQ basis from $0.1 in Q1 2024.
Biomarin Pharmaceutical (BMRN) Debt to Equity (2010 - 2024) Analysis & Trends
Biomarin Pharmaceutical has disclosed Debt to Equity across 15 years of filings, most recently posting $0.09 for Q2 2024.
- Quarterly Debt to Equity changed N/A year-over-year to $0.09 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $0.09 (changed N/A YoY) and the FY2023 annual result came in at $0.1, changed N/A from the prior year.
- Debt to Equity retreated to $0.09 in Q2 2024, from $0.1 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.11 in Q2 2020 and troughed at $0.01 in Q3 2022.
- A 5-year average of $0.05 and a median of $0.01 in 2022 frame the typical range for Debt to Equity.
- Annual changes were most pronounced in 2020 — Debt to Equity soared 3310.96% — and 2021, when it plunged 93.45%.
- Tracing BMRN's Debt to Equity over 5 years: stood at $0.09 in 2020, then sank by 87.75% to $0.01 in 2021, then tumbled by 45.21% to $0.01 in 2022, then surged by 1509.98% to $0.1 in 2023, then dropped by 6.15% to $0.09 in 2024.
- Business Quant data shows BMRN's Debt to Equity at $0.09 in Q2 2024, $0.1 in Q1 2024, and $0.1 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Biomarin Pharmaceutical | 10.52 Bn | 8.29 Bn | 571.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.09 |
| Mar 31, 2024 | 0.10 |
| Dec 31, 2023 | 0.10 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.01 |
| Sep 30, 2020 | 0.09 |
| Jun 30, 2020 | 0.11 |
| Mar 31, 2020 | 0.11 |
| Dec 31, 2019 | 0.12 |
| Sep 30, 2019 | 0.00 |
| Jun 30, 2019 | 0.00 |
| Mar 31, 2019 | 0.03 |
| Sep 30, 2018 | 0.03 |
| Jun 30, 2018 | 0.13 |
| Mar 31, 2018 | 0.13 |